NRF2: KEAPing Tumors Protected

Written By Gabriel de Souza

Pillai R, Hayashi M, Zavitsanou AM, Papagiannakopoulos T.

Cancer Discov. 2022 Mar 1;12(3):625-643. doi: 10.1158/2159-8290.CD-21-0922. PMID: 35101864

Click here to read

Gabriel de Souza
Previous

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
Next

EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion